Five patients 25% in Group I had associated pathological atrophy vs. 144 patients 69.9% in group II p <0.05. Three patients in Group 1 15% had associated intestinal metaplasia vs. 49 23.8% in group II.
Cinco pacientes 25% del grupo I tenía asociado atrofia en la patología contra 144 pacientes 69,9% del grupo II p < 0,05 y 3 15% metaplasia intestinal contra 49 23,8% del grupo II.